Portfolio Finder

HMC+ Exit

Production of chitin and chitosan-based high purity biopolymers. HMC develops new chitosan applications for the pharmaceutical industry, nanoparticles for drug delivery systems, and is a custom manufacturer of chitosan derivatives.

HTGF-Manager: Ulrike Kalapis
In portfolio 03. Jun 2008 – 23. Jun 2020

JeNaCell Exit

JeNaCell produces biotechnologically generated nanocellulose (BNC) in an IP protected, continuous and automated production process: high quality innovative products for applications in medicine, cosmetics and more.

KSK Diagnostics Exit

KSK Diagnostics GmbH uses its isothermal amplification technology, KDx rITA®, for the development of molecular point-of-care tests to identify pathogens and antimicrobial resistance within 30 minutes. This significantly reduces the time before therapy is started. In addition to the diagnosis of pathogens, KSK Diagnostics’ point-of-care tests are ideally suited to quickly and reliably clarifying issues related to tumour diagnostics.

Sector: New Materials
HTGF-Manager: Dr. Frank Hensel
In portfolio 03. Apr 2017 – 24. May 2018


Development of innovative, bioabsorbable products with a focus on medical applications.

HTGF-Manager: Kay G. Balster
In portfolio 11. Oct 2006 – 31. Oct 2018


multiBIND develops innovative solutions for molecular biology, healthcare and agriculture. bioDECONT® and bioCLEAN represent biocompatible disinfection and decontamination in laboratories, hospitals and agriculture.

Nebula Biocides

Nebula Biocides GmbH was founded in 2019 as a spin-off from the Leibniz Institute for Plasma Science and Technology (INP) by the scientists Dr. Jörn Winter, Dr. Ansgar Schmidt-Bleker and the director of INP Prof. Dr. Klaus-Dieter Weltmann. With the aim of providing comprehensive protection against infectious pathogens, the company develops application-oriented disinfection solutions that reliably kill not only bacteria and viruses but also persistent bacterial spores.

HTGF-Manager: Dr. Nikolaus Raupp
Added to portfolio 20. Sep 2021


Purenum is a spin-off of the Fraunhofer-IFAM and develops biocompatible adhesives for medical use. As part of a BMBF project (GO-Bio 6 "mediNiK"), an adhesive was developed that can be used to glue together and remove previously ungrippable kidney stone fragments after lithotripsy. In addition to work on the commercialisation of the kidney stone adhesive, Purenum is also developing adhesives for other medical indications.

HTGF-Manager: Dr. Anke Caßing
Added to portfolio 16. Jul 2018

traceless materials

The circular bioeconomy startup traceless materials has developed a holistically sustainable alternative for plastics and bioplastics that is fully compostable in nature, contributing to solve the global plastic pollution.

HTGF-Manager: Johannes Weber
Added to portfolio 23. Apr 2021